Related Experiment Videos
Deep Eutectic Solvent-Based Extraction Optimization, Structural Characterization, and Alleviating Effects of Tremella
Zhenhua Fan1, Qiuyun Li2, Weiliang Wu1
1Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.
None:
Tremella fuciformis polysaccharides (TFPS) exhibit anti-inflammatory and gut-microbiota-modulating activities, but conventional extraction methods often show limited efficiency and may affect polysaccharide structural integrity. This study optimized a deep eutectic solvent (DES)-based extraction method with potential environmental advantages for TFPS, characterized the major purified fraction, and evaluated its effects in a dextran sulfate sodium (DSS)-induced experimental colitis model. Extraction parameters for the choline chloride-lactic acid DES system were refined through single-factor testing combined with response surface methodology. The purified fraction TFPS-1 was characterized by chromatographic, spectroscopic, methylation, and NMR analyses, and its biological effects were assessed in DSS-treated mice. Under the optimized conditions, the TFPS yield reached 33.09 ± 1.52%, representing a 77.6% increase compared with hot-water extraction. TFPS-1 was identified as a low-molecular-weight glucan mainly containing α-(1→4)- and β-(1→6)-linked glucose residues. In experimental colitis mice, TFPS-1 alleviated body weight loss, colon shortening, and histopathological injury; increased mucus secretion and barrier-related gene expression; reduced pro-inflammatory cytokines; increased IL-10; and partially adjusted gut microbiota composition. These results indicate that DES-based extraction is an efficient strategy for preparing TFPS and provide evidence that TFPS-1 may be further explored as a food-derived polysaccharide ingredient for intestinal protection in experimental colitis-related contexts.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...